2023
Radiomic markers of intracerebral hemorrhage expansion on non-contrast CT: independent validation and comparison with visual markers
Haider S, Qureshi A, Jain A, Tharmaseelan H, Berson E, Zeevi T, Werring D, Gross M, Mak A, Malhotra A, Sansing L, Falcone G, Sheth K, Payabvash S. Radiomic markers of intracerebral hemorrhage expansion on non-contrast CT: independent validation and comparison with visual markers. Frontiers In Neuroscience 2023, 17: 1225342. PMID: 37655013, PMCID: PMC10467422, DOI: 10.3389/fnins.2023.1225342.Peer-Reviewed Original ResearchIndependent validation cohortIntracerebral hemorrhageRadiomic featuresValidation cohortClinical variablesHematoma expansionSpontaneous supratentorial intracerebral hemorrhageNon-contrast head CTSupratentorial intracerebral hemorrhageTomography (CT) of patientsNon-contrast headFuture clinical trialsNon-contrast CTIntracerebral Hemorrhage ExpansionHigh predictive valueBAT scoreHypertensive patientsClinical predictorsPrognostic relevanceFunctional outcomeClinical trialsHead CTHemorrhage expansionClinical trial datasetDiscovery cohort
2022
Deciphering the Clinical Trials of Immunotherapy in Glioblastoma: What a Neuroradiologist Needs to Know
Varzaneh F, Merkaj S, Petersen G, Bahar R, Jekel L, Pala A, Malhotra A, Ivanidze J, Aboian M. Deciphering the Clinical Trials of Immunotherapy in Glioblastoma: What a Neuroradiologist Needs to Know. Neurographics 2022, 12: 176-187. DOI: 10.3174/ng.2100055.Peer-Reviewed Original ResearchTreatment of glioblastomaClinical trialsTrial failuresImmune checkpoint inhibitorsMechanisms of immunotherapyPrimary intracranial neoplasmsCheckpoint inhibitorsSurgical resectionImmunotherapeutic approachesSurvival outcomesIntracranial neoplasmsRadiation therapyImmunotherapyGlioblastoma treatmentGlioblastomaMultidisciplinary approachTrialsTreatmentNeuroradiologistsPresent studyFuture directionsResectionChemotherapyFailurePrognosis